BioAge Labs announced its investigational pill for cardiovascular risk prevention significantly reduced inflammation markers in an early-stage clinical study, representing potential progress in heart disease prevention.
Early trial results presented at AACR show CAR-T cell therapy may prevent smoldering multiple myeloma from progressing to active disease in high-risk patients, representing a potential preventive approach to cancer treatment.
A landmark trial presented at ESCMID Global 2026 demonstrates that improving oral hygiene for hospital patients can reduce the risk of non-ventilator-associated hospital-acquired pneumonia by 60%, offering a simple intervention to prevent a serious complication.
Study finds women with epilepsy taking antiseizure medication who initiate high-dose folic acid before pregnancy have approximately 45% reduced risk of major congenital anomalies in their children.
Research from the University of Oulu suggests that large variations in bedtime during midlife may double the risk of cardiovascular events, highlighting the importance of consistent sleep schedules for heart health.
New research shows that influenza vaccination significantly reduces the risk of heart attack and stroke even among people who contract the flu after vaccination, demonstrating cardiovascular benefits beyond infection prevention.
